Veeva Streamlines Regulatory and Quality Operations at ICON
October 18 2016 - 9:04AM
Business Wire
Leading global biopharma outsourcing company
adopts Veeva Vault Study Startup following its success with Veeva
Vault eTMF
Today at the Veeva R&D Summit, to an audience of more than
600 industry leaders, Veeva Systems (NYSE:VEEV) today announced
that ICON, a global provider of drug development solutions and
services, is streamlining its regulatory and quality operations
with Veeva Vault applications to increase transparency and enable
greater collaboration with sponsors.
Veeva Vault provides ICON an integrated suite of best-in-class
applications that unify content and data for improved quality and
compliance across their global operations. Veeva Vault Submissions
delivers a single, authoritative source for ICON and their
affiliates and partners to speed the entire regulatory submission
preparation process – from authoring to assembly. Separately, Veeva
Vault QualityDocs improves GxP document management for greater
compliance, improved quality, and reduced operational overhead.
Communication, visibility, and process inefficiency are common
challenges between CROs and sponsors when data and content are
managed in multiple, disconnected systems. This hinders
collaboration and often creates duplicate work and content among
teams, introducing compliance risks that can delay time to
market.
With Veeva Vault at the heart of its regulatory and quality
operations, ICON has a single source of truth for regulatory
information and key quality policies and procedures that global
stakeholders can share in real time. Now ICON can provide its
sponsors and partners with full visibility into regulatory and
quality content for increased control and collaboration.
“Veeva Vault applications enable ICON to more easily collaborate
with sponsors on all documents throughout product development
lifecycles and streamline communications to shorten delivery
timeframes,” said Quintin van Wyk, vice president, safety,
regulatory, and writing services for ICON.
Faster, more efficient global submissions process
Vault Submissions will be part of ICON’s medical writing and
regulatory services as well as submissions management offering to
globalize their processes and make it easier to build and track
submissions content through approvals. Submission preparations are
fast and efficient, while meeting global compliance
requirements.
Improved audit readiness in quality
ICON is leveraging Vault QualityDocs to enable efficient routine
audits for its quality assurance department. The solution provides
real-time access to information, reducing compliance risk and
improving quality processes. In addition, ICON is now able to
expand its service offerings, including support for remote audits –
a service clients are requesting more often.
“Veeva Vault is a game-changer for many companies looking to
unify processes in regulatory, quality, clinical, and beyond,” said
Jennifer Goldsmith, senior vice president of Veeva Vault. “As the
level of activity between sponsors and contract services
organizations continues to increase, customers such as ICON will be
able to provide greater visibility, efficiency, and compliance for
their sponsors.”
In other news today, Veeva announced broad industry adoption of
its Veeva Vault Quality applications.
Additional Information
For more on Veeva Vault Submissions, visit:
veeva.com/eu/Submissions
For more on Veeva Vault QualityDocs, visit:
veeva.com/eu/QualityDocs
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
Follow us @veevasystems on Twitter: twitter.com/Veeva_EU
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the
global life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva has more than 450
customers, ranging from the world's largest pharmaceutical
companies to emerging biotechs. Veeva is headquartered in the San
Francisco Bay Area, with offices in Europe, Asia, and Latin
America. For more information, visit
https://www.veeva.com/eu/.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended July 31, 2016. This is available on
the company’s website at veeva.com under the Investors section and
on the SEC’s website at sec.gov. Further information on potential
risks that could affect actual results will be included in other
filings Veeva makes with the SEC from time to time.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161018006056/en/
Veeva Systems Inc.Sue Glanville / Cate
Bonthuyssue@catalystcomms.co.uk / cate@catalystcomms.co.uk+44 (0)
7715 817589 / +44 (0) 7746 546773
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2024 to May 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From May 2023 to May 2024